Search results for: 'aging drug industry'

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...

12 Jun 2023  |  Global  |  Technology Research

Industry Cloud Platforms: An End-to-end Specialized Solution

Data-driven Insights Boost the Industry Cloud Platform Growth Pipeline

Infographics

×

An industry cloud platform is designed to meet the specific needs of respective industries. It provides sector-specific solutions and services through the cloud, such as data analytics, machine learning, and asset management, to help organizations improve efficiency, reduce costs, and drive innovation. The adoption of industry cloud platforms is...

The space industry is no longer sustained by governmental bodies and aerospace and defense companies. In the modern space race, the private sector is dominating by discovering new opportunities regarding innovations and public-private partnerships. The term “NewSpace” heralds the arrival of private space company ventures. Start-ups, investors, ...

Top growth opportunities in the Aerospace & Defense program area cover the commercial aviation, spacecraft, unmanned systems, and defense markets. Technologies and services often overlap, and industry participants will have opportunities with civilian and military customers in 2023. The commercial aviation industry is on the rebound, with increasin...

The global space industry has been expanding with the entry of new participants and non-space companies that are extending their roles to cater to both the upstream and the downstream segments. The upstream segment is expanding exponentially and is seeing successful launches by low earth orbit (LEO) satellite constellation operators as well as plan...

Technological advancements are disrupting the healthcare industry. There is an increasing trend toward personalized and precise medical treatments, such as personalized genomics, which provide outputs at a much lower cost and at a faster speed than has ever been possible. Precision medicine has also driven the development of targeted drug delivery,...

This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent technology advances across cell & gene therapies, immunotherapies, intelligent drug discovery approaches, automated biomanufacturing and microbiome sciences. The TOE also encompasses recent developments in proteomics, drug deliver...